Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients

NCT00433953 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

44

Enrollment

OTHER

Sponsor class

Stopped No longer following patient and no plans to publish.

Conditions

Kidney Transplant

Interventions

DRUG: Mycophenolate Mofetil (CellCept)
BEHAVIORAL: Dietary Monitoring
BEHAVIORAL: Drug Diary
PROCEDURE: Blood Sampling

Sponsor

Children's Hospital Medical Center, Cincinnati